"It feels like it was almost a confirmation the company is moving in a more commercial direction". @axios's Senior AI Reporter @MadisonMills22 spoke with Deepmind employees about Demis' new role: "For some of them it feels like Demis was banging the drum on the need to focus on AGI, focus on science, focus on curing cancer". "Then their parent company said 'okay let's move you over to the side in a little sandbox where you can go do that and then we can focus on making money".